dexamethasone
Not Tagged
['krd ']
seeing elo-krd vs krd trial at #asco23 makes me contemplate: will we see entire decade of large 4 vs 3 trials of drugs known to be active in myeloma, powered for obvious endpoints (such as a single time-point of mrd neg)? i hope we use our resources to answer imp q 
Cancer doctor at @huntsmancancer with interest in myeloma, supportive care, end of life, cost-effective/evidence-based care and med-ed. No COI. Views own.